Technical Analysis for LNTH - Lantheus Holdings, Inc.

Grade Last Price % Change Price Change
grade B 24.08 -0.70% -0.17
LNTH closed down 1.28 percent on Monday, May 20, 2019, on 69 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical LNTH trend table...

Date Alert Name Type % Chg
BB Squeeze Ended Range Expansion 0.58%
Lower Bollinger Band Touch Weakness 0.58%
Evening Star Bearish -0.70%
Fell Below 20 DMA Bearish -0.70%
Fell Below 50 DMA Bearish -0.70%
MACD Bearish Signal Line Cross Bearish -0.70%
Expansion Pivot Sell Setup Bearish Swing Setup -0.70%
Bollinger Band Squeeze Range Contraction -0.70%
MACD Bullish Signal Line Cross Bullish -6.30%
Pocket Pivot Bullish Swing Setup -6.30%

Older signals for LNTH ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Lantheus Holdings, Inc. is engaged in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. The Company's medical imaging agents are used to diagnose coronary artery disease, congestive heart failure, stroke, peripheral vascular disease and other diseases. The Company's products include contrast agents and medical radiopharmaceuticals, including technetium generators. The Company's products include DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, Neurolite, Thallium Tl 201, Gallium Ga 67, Gludef, Quadramet and Ablavar. The Company is also engaged in developing agents, such as Flurpiridaz F 18, which is a myocardial perfusion imaging agent; 18F LMI 1195, which is a cardiac neuronal imaging agent, and LMI 1174, which is a vascular remodeling imaging agent.
Medicine Chemistry Diseases Chemical Elements Medical Imaging Medical Physics Coronary Artery Disease Peripheral Vascular Disease Stroke Medicinal Radiochemistry Radiopharmaceuticals Congestive Heart Failure Cardiovascular And Other Diseases F 18
Is LNTH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 26.4
52 Week Low 12.59
Average Volume 346,143
200-Day Moving Average 18.3124
50-Day Moving Average 24.6908
20-Day Moving Average 24.9425
10-Day Moving Average 24.929
Average True Range 0.9848
ADX 19.18
+DI 21.798
-DI 23.668
Chandelier Exit (Long, 3 ATRs ) 23.4456
Chandelier Exit (Short, 3 ATRs ) 26.2344
Upper Bollinger Band 26.0824
Lower Bollinger Band 23.8026
Percent B (%b) 0.06
BandWidth 9.140223
MACD Line 0.058
MACD Signal Line 0.1887
MACD Histogram -0.1307
Fundamentals Value
Market Cap 894.15 Million
Num Shares 37.3 Million
EPS 0.73
Price-to-Earnings (P/E) Ratio 32.79
Price-to-Sales 2.17
Price-to-Book 0.00
PEG Ratio 0.69
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.83
Resistance 3 (R3) 24.82 24.53 24.68
Resistance 2 (R2) 24.53 24.30 24.53 24.63
Resistance 1 (R1) 24.23 24.16 24.09 24.24 24.58
Pivot Point 23.94 23.94 23.86 23.94 23.94
Support 1 (S1) 23.64 23.71 23.50 23.65 23.30
Support 2 (S2) 23.35 23.57 23.35 23.25
Support 3 (S3) 23.05 23.35 23.20
Support 4 (S4) 23.06